• Immunohistochemistry analysis of paraffin-embedded human brain tissue, using RFX3 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of lysates from COLO and RAW264.7 cells, using RFX3 Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using RFX3 Polyclonal Antibody cells nucleus extracted by Minute TM Cytoplasmic and Nuclear Fractionation kit (SC-003, Inventbiotech, MN, USA).

Anti-RFX3 antibody (641-690 aa) (STJ95431)

SKU:
STJ95431

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Transcription factor RFX3 (641-690 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:40000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: RFX3
Gene ID: 5991
Uniprot ID: RFX3_HUMAN
Immunogen Region: 641-690 aa
Specificity: RFX3 Polyclonal Antibody detects endogenous levels of RFX3 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human RFX3 at the amino acid range 641-690
Protein Name Transcription Factor Rfx3
Regulatory Factor X 3
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Transcription Factor Rfx3 antibody
Anti-Regulatory Factor X 3 antibody
Anti-RFX3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance